SCHEMBL7473612

SCHEMBL7473612

CC(C(=O)O)N(C(=O)OCc1ccccc1)C(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.42
MAPK1 P28482 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 2/20 0.41
ABCB1 P08183 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SLC15A1 P46059 1/20 0.41
POLB P06746 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CCR6 P51684 1/20 0.40
PAX8 Q06710 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7382333 1.00 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
Glycolic Acid SCHEMBL1813600 0.95 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
SCHEMBL11662689 0.85 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
SCHEMBL9219335 0.83 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
SCHEMBL5421388 0.83 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
SCHEMBL31422729 0.83 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
SCHEMBL2957718 0.82 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
SCHEMBL5146905 0.82 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
Carbamic Acid SCHEMBL28819973 0.82 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2
SCHEMBL8043863 0.81 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2L3MBTL1MAPK1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0950046-B1 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS NAEJA PHARMACEUTICAL INC (CA) 2002-04-10 EP claimed